Pruim, J.

(Jan Pruim)

patient fdg-pet tumor response cancer esophageal cancer study esophageal surgery value chemoradiotherapy neoadjuvant result center responder response assessment histopathologic assessment nonresponder imaging department histopathologic responders treatment model therapy neoadjuvant chemoradiotherapy outcome table signi tomography preoperative positron emission tomography resection mandard pet /ct signi ﬁcantly carcinoma amsterdam length method cell carcinoma adenocarcinoma decrease cutoff score william emission histopathologic response lippincott resectable wilkin regression j clin oncol positron resectability netherland histological type trial tumor cells oncol chemoradiation uptake identi curable esophageal cancer resection specimen 0.001 lymph nodes suv decrease j nucl med analysis procedure number change \0.001 fdg uptake curve identi ﬁed pet scan metastase speci ﬁcity

2 Most Recent Publications

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer? (Article)
Schreurs, L.M.A. Janssens, A.C.J.W. Plukker, J.T. Groen, H.J.M. Fockens, P. Dullemen, H.M. van Berge Henegouwen, M.I. van Sloof, G.W. Pruim, J. Lanschot, J.J.B. van Steyerberg, E.W.

2011-05-06

Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer (Article)
Heijl, M. van Omloo, J.M. Nieuwenhuijzen, G.A.P. Bonenkamp, J. Plukker, J.T. Cuesta, M.A. Kate, F.J.W. ten Pruim, J. Dekken, H. van Bergman, J.J.G.H.M. Sloof, G.W. Lanschot, J.J.B. van Berge Henegouwen, M.I. van Hoekstra, O.S. Boellaard, R. Bossuyt, P.M.M. Busch, O.R.C. Tilanus, H.W. Hulshoff, M. Gaast, A. van der

2011-01-01

Message*:
Your Email Adress*:
	*: Required fields, please provide an email address so that the RePub team can contact you if needed.